PAK1 and colonic neoplasm: Accordingly, PAK1 overexpression partially overcomes the 5-fluoro-uracile (5-FU) -induced growth inhibition of human colon cancer cells xenografted in -SCID mice, whereas PAK1 inhibition acts in synergy with 5-FU treatment 36.